GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / US Biomax / Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed / Product Detail : OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed
#OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed
Product name : Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed
Catalog number : OV1004
Supplier name : US Biomax
Data sheet: Ask more or other datasheet now !
About this Product :Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed.
Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed storing antibdies for longer storage periods of the Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed we recommend - 21C or lower and for short periods lees than 1 month we suggest +5C fridge temperatures.
More Details about
|Microarray Panel:||Ovarian carcinoma tissue microarray for antibody screening, containing 40 cases of ovarian cancer (31 serous adenocarcinoma，5 endometrioid adenocarcinoma，3 mucinous adenocarcinoma，1 clear-cell carcinoma), 10 normal tissue, duplicate cores per case, divided into two identical 50 cores arrays|
|Layout:||10 cols × 10 rows|
|Core Diameter:||1 mm|
|Quality Control:||Anti-Actin confirmed|
|Applications:||Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.|
|Notes:||Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.|
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases_100 cores; ihc Anti-Actin confirmed
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1003: Ovarian Infertility Genes
WP1019: FAS pathway and Stress induction of HSP regulation
WP1062: Regulation of Actin Cytoskeleton
WP1120: Ovarian Infertility Genes
WP1138: FAS pathway and Stress induction of HSP regulation
WP1178: Regulation of Actin Cytoskeleton
WP1340: Ovarian Infertility Genes
WP1380: Regulation of Actin Cytoskeleton
WP1589: Folate-Alcohol and Cancer Pathway
WP1963: The effect of Glucocorticoids on target gene expression
WP1968: genetic alternations of lung cancer
WP1971: Integrated Cancer pathway
WP1984: Integrated Breast Cancer Pathway
WP2107: pathways in human cancer
WP2256: Integrated Pancreatic Cancer Pathway
WP2263: Prostate Cancer
WP2272: Pathogenic Escherichia coli infection
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP2292: Chemokine signaling pathway
WP2335: sGC Cancer
WP2361: Gastric cancer network 1
WP2363: Gastric cancer network 2
WP2367: Private Pancreatic Cancer
WP2377: Integrated Pancreatic Cancer Pathway
WP2411: Cancer prevention Q
Related Genes :
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 6.3.2.-) (RING finger protein 53)
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[CTNNB1 CTNNB OK/SW-cl.35 PRO2286] Catenin beta-1 (Beta-catenin)
[Dab2 Doc2] Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Mitogen-responsive phosphoprotein)
[FOLR1 FOLR] Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18)
[BRCA2 FACD FANCD1] Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein)
[MUC16 CA125] Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125)
[DAB2 DOC2] Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Differentially-expressed protein 2)
[ERBB2 HER2 MLN19 NEU NGL] Receptor tyrosine-protein kinase erbB-2 (EC 18.104.22.168) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340)
[ENOX2 COVA1] Ecto-NOX disulfide-thiol exchanger 2 (APK1 antigen) (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)]
[FMR1] Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1) (FMRP) (Protein FMR-1)
[SEPT9 KIAA0991 MSF] Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1)
[SPIN1 OCR SPIN] Spindlin-1 (Ovarian cancer-related protein) (Spindlin1)
[TTN] Titin (EC 22.214.171.124) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)
[Bcl2l11 Bim Bod] Bcl-2-like protein 11 (Bcl2-L-11) (Bcl-2-related ovarian death protein) (Bcl2-interacting mediator of cell death)
[LMNA LMN1] Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)]
[Dab2 Doc2] Disabled homolog 2 (Adaptor molecule disabled-2) (C9) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Mitogen-responsive phosphoprotein)
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 126.96.36.199) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[lok CG10895] Ovarian-specific serine/threonine-protein kinase Lok (EC 188.8.131.52) (Protein loki) (dMNK)
[LRRK2 PARK8] Leucine-rich repeat serine/threonine-protein kinase 2 (EC 184.108.40.206) (Dardarin)
[AKT1 PKB RAC] RAC-alpha serine/threonine-protein kinase (EC 220.127.116.11) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
[CDH1 CDHE UVO] Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3]
[GPR68 OGR1] Ovarian cancer G-protein coupled receptor 1 (OGR-1) (G-protein coupled receptor 68) (GPR12A) (Sphingosylphosphorylcholine receptor)
[MDM2] E3 ubiquitin-protein ligase Mdm2 (EC 6.3.2.-) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (p53-binding protein Mdm2)
[DICER1 DICER HERNA KIAA0928] Endoribonuclease Dicer (EC 18.104.22.168) (Helicase with RNase motif) (Helicase MOI)
[BEX3 DXS6984E NADE NGFRAP1] Protein BEX3 (Brain-expressed X-linked protein 3) (Nerve growth factor receptor-associated protein 1) (Ovarian granulosa cell 13.0 kDa protein HGR74) (p75NTR-associated cell death executor)
[BAX BCL2L4] Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4)
[DPH1 DPH2L DPH2L1 OVCA1] Diphthamide biosynthesis protein 1 (DPH1 homolog) (HsDph1) (Diphthamide biosynthesis protein 2 homolog-like 1) (DPH-like 1) (DPH2-like 1) (Diphthamide biosynthesis protein 2-like) (Ovarian cancer-associated gene 1 protein)
[N CG3936] Neurogenic locus Notch protein [Cleaved into: Processed neurogenic locus Notch protein]
[PARK2 PRKN] E3 ubiquitin-protein ligase parkin (Parkin) (EC 6.3.2.-) (Parkinson juvenile disease protein 2) (Parkinson disease protein 2)
 Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience.
 miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis.
 IL-17A exacerbates cisplatin-based resistance of OVCA via upregulating the expression of ABCG2 and MDR1 through Gli1-mediated Hh signaling.
 Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?
 Millepachine, a potential topoisomerase II inhibitor induces apoptosis via activation of NF-κB pathway in ovarian cancer.
 Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.
 The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.
 Unexpected Findings in Magnetic Resonance Enterography and Their Clinical Significance.
 In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer.
 Choline Metabolism Alteration: A Focus on Ovarian Cancer.
Enter catalog number :